Pregnolia AG is a women's health medtech company based in Switzerland. Our company is at the stage of early commercialisation. We focus on a diagnostic device to identify women at risk for premature birth. Early risk detection will allow gynecologists to make key decisions about preterm birth management. Pregnolia's technology addresses both the health and economic challenge of preterm birth worldwide.